ImageneBio Stock (NASDAQ:IMA)
Previous Close
$16.37
52W Range
$11.65 - $23.28
50D Avg
$15.73
200D Avg
$17.19
Market Cap
-
Avg Vol (3M)
$17.82K
Beta
-
Div Yield
-
IMA Company Profile
Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis
Industry
Biotechnology
Sector
Healthcare
Exchange
NASDAQ
ADR
-
Country
US
Employees
-
IPO Date
Feb 27, 1998
Website
-